-
公开(公告)号：US20230314440A1
公开(公告)日：2023-10-05
申请号：US18022209
申请日：2021-08-20
Applicant: Exelixis, Inc.
Inventor： Christopher Del Nagro , Jason Wall , Evelyn Wang , Chih-Jian Lih
IPC: G01N33/574
CPC classification number: G01N33/57492 , G01N2800/52
Abstract: This invention is directed to the treatment of cancer, particularly solid tumors, using cabozantinib in combination with an immune checkpoint inhibitor or an anti-cancer vaccine and in predicting responses to such cancer treatments.
Search Results
1
records
(took 0.009 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
